|
ATP11C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.506050E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.084200E-03 |
| Normal-vs-Stage2 |
8.799000E-01 |
| Normal-vs-Stage3 |
1.943990E-01 |
| Normal-vs-Stage4 |
1.273180E-01 |
| Stage1-vs-Stage2 |
2.593400E-01 |
| Stage1-vs-Stage3 |
2.032300E-02 |
| Stage1-vs-Stage4 |
6.716400E-01 |
| Stage2-vs-Stage3 |
4.212800E-01 |
| Stage2-vs-Stage4 |
3.171200E-01 |
| Stage3-vs-Stage4 |
3.549500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.777600E-02 |
| Normal-vs-AfricanAmerican |
8.930800E-01 |
| Normal-vs-Asian |
7.157600E-01 |
| Caucasian-vs-AfricanAmerican |
1.843570E-01 |
| Caucasian-vs-Asian |
5.190000E-01 |
| AfricanAmerican-vs-Asian |
6.753000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.248300E-02 |
| Normal-vs-Female |
7.335200E-01 |
| Male-vs-Female |
3.588000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.152010E-01 |
| Normal-vs-Extreme_Weight |
6.395100E-03 |
| Normal-vs-Obese |
7.601000E-01 |
| Normal-vs-Extreme_Obese |
3.053900E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.448800E-01 |
| Normal_Weight-vs-Obese |
2.478000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.487600E-01 |
| Extreme_Weight-vs-Obese |
2.865600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.401200E-01 |
| Obese-vs-Extreme_Obese |
2.499200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.030000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.864600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.515800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.586400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.672400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.864300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.791780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.869700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.800600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.372200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.785900E-02 |
| Normal-VS-Type2 PRCC |
6.030800E-01 |
| Normal-VS-KIRP CIMP |
5.248400E-01 |
| Normal-VS-Unclassified PRCC |
8.487600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.145600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.396550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.639190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.933800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.963400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.692200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.453400E-01 |
| Normal-vs-N1 |
3.751200E-01 |
| Normal-vs-N2 |
7.285400E-01 |
| N0-vs-N1 |
2.403000E-01 |
| N0-vs-N2 |
9.485200E-01 |
| N1-vs-N2 |
6.387200E-01 |
|
|
